Die sichersten Peptide für Muskelaufbau + Gewichtsverlust

Glutathion, ein körpereigenes Tripeptid mit einer Aminosäuresequenz aus Cystein, Glutaminsäure und Glycin, ist im Handel oft unter dem Namen GSH erhältlich. Dieses starke antioxidative Molekül wird von der Leber und den Neuroglia in unserem Körper produziert.

Glutathion spielt eine Schlüsselrolle bei der Entgiftung und der Beseitigung aller Oxidantien und Fängerpartikel, die im menschlichen Körper aufgrund verschiedener biochemischer Prozesse entstehen. Es ist wichtig zu erwähnen, dass eine der Hauptaufgaben von Glutathion darin besteht, die roten Blutkörperchen zu schützen, da diese anfälliger für oxidativen Stress sind.

Da der Glutathionspiegel mit zunehmendem Alter sinkt, sind wir anfälliger für die Entwicklung von Krebs und anderen damit zusammenhängenden Erkrankungen. Daher kann man die Rolle von Glutathion auch mit der Verzögerung des Auftretens und Fortschreitens von Krebs in Verbindung bringen.

HGH-FRAG ist eine geschnittene Version des menschlichen Wachstumshormons. Es enthält die letzten 16 Aminosäuren der 191 langen Sequenz von HGH. Chemisch gesehen hat das Peptid die Bezeichnung C39H60N8O13.

Im Gegensatz zu HGH hat das HGH-FRAG jedoch einen ganz anderen Wirkmechanismus. Man sollte meinen, dass die HGH-Fragmente, die ein gespleißter Teil des Wachstumshormons sind, auch auf die gleiche Weise funktionieren würden. Die Antwort lautet jedoch nein.

Anders als sein Elternteil GH bindet HGH-FRAG nicht an Wachstumshormonrezeptoren (GHR), da es nicht aus allen 191 Aminosäuren besteht. Daher kann es weder die Bildung von IGF-1 anregen noch anabole Funktionen ausüben, wie es GH tun würde.

Forschungsergebnisse deuten darauf hin, dass eine dreiwöchige HGH-FRAG-Therapie bei fettleibigen Mäusen zu einer ungefähren Verringerung der Gewichtszunahme um 50% führte.

Thymosin beta-4 is a small peptide with G actin-sequestering action. It is associated with the induction of angiogenesis and accelerated wound healing (10).

TB-500 is a synthetic version of the naturally occurring peptide LKKTETQ. The peptide segment (17)LKKTETQ(23) is the active site within the protein thymosin β(4) responsible for actin binding, cell migration and wound healing

Muscle fibers are made up of actin and myosin, which are contractile filaments. These filaments allow our muscles to contract and relax for mobility and carry out efficient metabolism and cell signaling.

TB-500 increases our body’s response to actin by increased reception of the protein by the peptide segment (17)LKKTETQ(23). This upregulation promotes increased cell growth, healthy cell proliferation, healing effects, and cell migration, particularly keratinocytes and endothelial cells.

TB-500 promotes angiogenesis which is the formation of new blood vessels. It builds up new blood vessel pathways for efficient blood supply to the wounds for increased healing. It also augments beneficial inflammation at the site of injuries.

BPC-157, or pentadecapeptide, is categorized as a body protection compound. It is composed of 15 amino acids in a very particular sequence that doesn’t exist naturally.

It is artificially synthesized in laboratories using the partial sequence of the body-protecting compounds isolated from gastric juices. Hence, it is one of the derivatives of the peptide found in human gastric juices.

The therapeutic effects of BPC-157 are exerted through multiple courses of action. One of the most common ways that BPC-157 acts as a therapeutic agent is by carrying out angiogenesis, which is the formation of new blood vessels. 

It does this by activating a protein called the “vascular endothelial growth factor” which initiates the formation of new blood vessels. This ensues in the organization of a healthy vascular network which gives BPC-157 its key regenerative and healing properties.

Another mechanism of action of BPC-157 is blocking the inhibitory growth factor called 4-hydroxynonenal, which is a negative modulator of growth. This allows the peptide to carry out effective healing of wounds, especially surrounding tendons.

Ipamorelin stands out as a potent pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) with remarkable growth hormone (GH)-releasing properties, both in vitro and in vivo. This selective growth hormone-releasing peptide has garnered attention as a promising solution for female fat loss.

Scientific investigations reveal that Ipamorelin has the potential to elevate the body’s natural growth hormone production by an impressive 30%. Given the pivotal role of growth hormone in fat metabolism, this elevation becomes crucial for achieving effective fat loss.

As women, especially those aged 40 and above, experience a decline in natural growth hormone levels, their metabolism tends to slow down, leading to increased fat storage. Ipamorelin’s capacity to boost these levels can counteract this decline, potentially accelerating fat loss by up to 20%.

What sets Ipamorelin apart is its unique characteristic of not stimulating appetite, distinguishing it from other growth hormone stimulants. This feature allows women to harness its fat-burning properties without the counterproductive urge to consume more calories.

Furthermore, a compelling study demonstrated that individuals incorporating Ipamorelin into their regimen experienced a notable 14% reduction in visceral fat over a 12-week period. Visceral fat, often deemed „dangerous fat,“ is associated with various health risks, underscoring the importance of its reduction for overall well-being.

In summary, Ipamorelin presents a scientifically backed approach to female fat loss by elevating growth hormone levels, hastening metabolism, and reducing detrimental visceral fat—all achieved without triggering an increased appetite. This makes Ipamorelin a promising avenue for those seeking an effective and well-rounded solution to enhance their overall body composition.